Strategy and market access consulting powered by human and artificial intelligence.

The life sciences consulting firm that combines the best human expertise with the latest AI technologies. We design pioneering strategies for global market access, drug pricing and pharmaceutical product development.

AI-native strategy and market access consulting.

Consulting services combining seasoned strategists with AI specialists.

More about us

To help you win in a rapidly evolving environment, we built a unique strategy and market access consulting practice that blends teams of seasoned consultants with AI specialists.

This combination of skills allows us to delegate low-value tasks to advanced tools and focus our time on providing you with higher quality insights and recommendations.

Pioneering ways to predict drug market evolution and inform clinical development, global market access, and pricing strategies.

Discover our services

Selecting and sequencing indications, identifying target populations, defining positioning, and setting price levels all profoundly impact commercial success and patient access.

These strategic decisions demand best-in-class intelligence and predictive ElevioSight models to project and understand future market conditions.

Experienced consultants, global expertise and AI technologies.

Experienced consultants in global market access and strategic drug development.

We are an international team of experienced consultants from established strategy firms and AI specialists with a strong background in life sciences. We have contributed to the clinical development, value maximization and launch of more than 50 drugs, including some of today's most successful blockbusters. We've seen our strategies pay off over time in immunology, oncology, vaccines, cardiovascular, and metabolic therapies.

Our team brings decades of combined experience in pharmaceutical strategy, having worked with global leaders in the industry. We understand the complexities of bringing innovative treatments to market and the challenges of navigating regulatory landscapes across different regions.

A unique network of experts engaged to challenge conventional thinking.

We assembled an elite team of renowned local pricing and reimbursement specialists, payers, key opinion leaders, and negotiation specialists. Our approach to collaborating and engaging with our experts is unique. We aim to challenge conventional thinking to go beyond the obvious solutions.

This network spans across major markets globally, providing us with real-time insights into healthcare systems, payer dynamics, and market access strategies. Our experts actively participate in shaping healthcare policies and reimbursement frameworks, giving us unparalleled insight into future market conditions.

AI-native consulting.

We believe every innovative product deserves a custom-made, boundary-pushing approach, where our "brains" meet AI-powered "brawn" to deliver maximum impact. We harness the unique synergy of our market access strategists and AI engineers to drive efficiency, focusing on high-value activities while delegating low-value tasks to AI. Our advanced market access and pricing tools, seamlessly integrating AI and big data, generate deeper insights on the strategies that will create value in the future.

By leveraging machine learning and predictive analytics, we can simulate market scenarios, forecast pricing outcomes, and optimize launch strategies with unprecedented accuracy. Our proprietary AI models continuously learn from real-world outcomes, ensuring our recommendations stay ahead of market evolution.

Experienced consultants, global expertise and AI technologies.

Global Market Access Icon

Global market access and pricing strategy.

We are relentlessly committed to elevating the level of insights and intelligence to develop high-quality market access and pricing deliverables. We go beyond the obvious solutions to maximize value.

Our approach combines deep market understanding with advanced analytics to ensure your products achieve optimal pricing and reimbursement across all major markets. We navigate complex payer landscapes and regulatory requirements to secure the best possible access for your innovations.

Our services include:

Market access landscaping and payer research
Access and pricing strategy
Market access plan
Stakeholder and ecosystem engagement plan
Value communication and objection handling
Negotiation guide and training
Get in touch with us
Drug Development Icon

Drug development strategies and predictive models.

We develop unique AI-powered predictive models — ElevioSight — to simulate future scenarios. We factor in competitor launches, strategic moves, and policy shifts and forecast how they will impact prices, revenues, profits, and patient reach.

Our predictive capabilities enable you to make informed decisions early in development, optimizing your clinical and commercial strategies to maximize value. We leverage real-world data, competitive intelligence, and market dynamics to provide actionable insights that drive strategic decision-making.

Our services include:

Indication prioritization and sequencing
Life cycle management strategy
Clinical development strategy and trial design to maximize value
Strategic due diligences
Portfolio optimization
Get in touch with us

Our team supported some of the most successful pharmaceutical and biotech companies.

200+

projects.

150+

clinical trials informed.

90%

recurring clients.

50+

product launches.

$100B

total peak sales.

50+

global and local experts.

Get started with us

Pursue your career in an AI-native Life Sciences consulting firm.

Market access strategist.

We are seeking a market access specialist (5+ years of relevant experience) to join our strategy consulting team. In this role, you will develop and implement global pricing, reimbursement, and market access strategies for leading life sciences organizations.

If you have strong analytical skills, a consulting and strategic mindset, and a passion for improving healthcare, we invite you to apply.

Apply

AI engineer.

We are seeking an AI engineer (2+ years of relevant experience) to join our data science team. In this role, you will design, build, and deploy advanced predictive models and LLMs that drive strategic insights for leading life sciences organizations.

If you have strong programming skills, a passion for data-driven innovation, and a desire to make an impact, we invite you to apply.

Apply

Trusted by leading pharmaceutical and biotech companies.

"ProDigitalConsulting helped us navigate complex market access challenges across multiple regions. Their AI-powered insights gave us a competitive edge in pricing strategy that exceeded our expectations."

Cheryl

Cheryl Thompson

VP of Market Access, Global Pharma Inc.

"The team's expertise in both strategy and AI technology is unmatched. They delivered predictive models that transformed how we approach drug development and commercialization decisions."

Partner

Michael Chen

Chief Strategy Officer, BioTech Solutions

"Working with ProDigitalConsulting was a game-changer for our product launch. Their deep understanding of payer dynamics and reimbursement strategies helped us achieve optimal market access."

Sarah Rodriguez

Head of Commercial Strategy, LifeScience Partners

"Their AI-native approach sets them apart. The ElevioSight models provided actionable insights that helped us prioritize indications and optimize our clinical development strategy."

David Kim

Director of Portfolio Strategy, MedTech Innovations

"The combination of seasoned consultants and AI specialists delivered results beyond traditional consulting. Their insights on global pricing strategy were instrumental to our success."

Emily Patterson

VP of Business Development, Advanced Therapeutics

"Outstanding work on our market access plan. The team's ability to blend human expertise with advanced analytics gave us confidence in our go-to-market strategy."

James Morrison

Chief Commercial Officer, Precision Medicine Group

Everything you need to know about our services.

We are an AI-native consulting firm that combines seasoned life sciences strategists with AI specialists. This unique approach allows us to deliver higher quality insights by delegating low-value tasks to advanced AI tools while our experts focus on strategic, high-value activities. Our proprietary ElevioSight predictive models provide unprecedented foresight into market dynamics.

We work with leading pharmaceutical and biotech companies across all stages of development—from early-stage biotechs to established global pharmaceutical organizations. Our clients range from those developing breakthrough therapies to companies optimizing their commercial strategies for existing products.

Our ElevioSight models use machine learning and predictive analytics to simulate future market scenarios. We factor in competitor launches, strategic moves, policy shifts, and market dynamics to forecast their impact on prices, revenues, and patient access. This data-driven foundation empowers our consultants to develop more informed, robust strategies.

Project timelines vary based on scope and complexity. A focused market access strategy might take 8-12 weeks, while comprehensive drug development strategies can span 3-6 months. We work flexibly to meet your deadlines and can accelerate timelines when needed, leveraging our AI tools to deliver insights faster than traditional approaches.

We operate globally with deep expertise across major markets including the US, EU5, Japan, and emerging markets. Our network includes 50+ local pricing and reimbursement specialists, payers, and market access experts who provide on-the-ground insights and support for region-specific strategies.

Getting started is simple. Reach out via our contact form or email, and we'll schedule an initial consultation to understand your needs and challenges. We'll then propose a customized approach and timeline. Most clients see initial insights within the first few weeks of engagement.

Deliverables are tailored to your project but typically include strategic recommendations, detailed market analyses, pricing models, implementation roadmaps, and executive presentations. For AI-powered projects, you'll also receive access to our predictive models and scenario planning tools that you can continue to use beyond the engagement.

Absolutely. We have expertise across the entire product lifecycle—from indication prioritization and clinical development strategy in early stages to market access planning, pricing strategy, and launch optimization for late-stage and commercial products. Our team has supported over 50 successful product launches across diverse therapeutic areas.

For more information about our team, services, or jobs, please contact us.